Table 1.
Patients characteristics.
| At Entry (SVR24) | 1 Year after SVR24 | |
|---|---|---|
| n = 734 | n = 501 | |
| Age (years) | 65.9 ± 12 | 67.1 ± 12 |
| Sex (male/female) | 291/443 | 194/307 |
| Albumin (g/dL) | 4.32 ± 0.4 | 4.30 ± 0.4 |
| Bilirubin (mg/dL) | 0.67 ± 0.3 | 0.73 ± 0.3 |
| AST (IU/L) | 24.7 ± 8.1 | 23.7 ± 8.0 |
| ALT (IU/L) | 17.6 ± 9.0 | 17.5 ± 9.0 |
| Platelet counts (×104/μL) | 17.0 ± 5.6 | 17.7 ± 5.6 |
| WFA±M2BP (COI) | 1.52 ± 1.4 | 1.28 ± 1.1 |
| AFP (ng/mL) | 3.99 ± 3.4 | 3.51 ± 2.2 |
| Presence of LR3/4 nodules | 21 (2.9%) | 9 (1.8%) |
| Histological fibrosis stage (1/2/3/4) | 64/75/88/30 |
AST, aspartate aminotransferase; ALT, alanine aminotransferase; WFA±M2BP, Wisteria floribunda agglutinin-positive mac-2 binding protein; COI, cut off index; AFP, alpha fetoprotein; LR, liver imaging reporting and data system; LR3, intermediate probability of HCC; LR4, probably of HCC.